A compound of general formula (I) wherein R 1 and R 4 are independently selected from the group consisting of hydrogen and (C 1 -C 4 )alkyl; R 2 and R 3 are independently selected from the group consisting of hydrogen and (C 1 -C 4 )alkyl; or R 2 and R 3 together with the carbon atom to which they are attached form a cyclopropyl, cyclobutyl, cyclopentyl, oxetanyl, tetrahydrofuranyl, or tetrahydropyranyl ring; n = 0, 1 or 2; Q is -O-C(O)-R 5 ; R 5 is selected from the group consisting of (C 1 -C 6 )alkyl, (C 3 -C 6 )cycloalkyl, halo(C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkoxy(C 1 -C 6 )alkyl, aryl; wherein said aryl is optionally substituted with one or more substituents independently selected from R 6 , or wherein said aryl is optionally benzodioxole; and wherein said (C 1 -C 6 )alkyl, (C 3 -C 6 )cycloalkyl are optionally substituted with one or more substituents independently selected from R 7 ; R 6 consists of halogen, cyano, hydroxyl, (C 1 -C 4 )alkyl, halo(C 1 -C 4 )alkyl, (C 1 -C 4 )alkyloxy, - S(O) 2 R x , -S(O) 2 NR a R b , -C(O)R x , -C(O)NR a R b and -OR x ; R 7 consists of halogen, hydroxyl, cyano, (C 1 -C 4 )alk0xy, -C(O)NR a R b , -C(O)OR a , -S(O) 2 R x , -S(O) 2 NR a R b , -OR x , and -SR x ; R x consists of (C 1 -C 6 )alkyl and (C 3 -C 6 )cycloalkyl; R a and R b are independently selected from the group consisting of hydrogen, (C 1 -C 4 )alkyl, phenyl-(C 1 -C 4 )alkyl, or R a and R b together with the nitrogen to which they are attached form a 4-6 membered heterocycloalkyl, wherein said heterocycloalkyl is optionally substituted with one or more (C 1 -C 4 )alkyl, -C(O)R x ; or pharmaceutically acceptable salts, hydrates or solvates thereof. R 1 and R 4 are independently selected from the group consisting of hydrogen and (C 1 -C 4 )alkyl; R 2 and R 3 are independently selected from the group consisting of hydrogen and (C 1 -C 4 )alkyl; or R 2 and R 3 together with the carbon atom to which they are attached form a cyclopropyl, cyclobutyl, cyclopentyl, oxetanyl, tetrahydrofuranyl, or tetrahydropyranyl ring; n = 0, 1 or 2; Q is -O-C(O)-R 5 ; R 5 is selected from the group consisting of (C 1 -C 6 )alkyl, (C 3 -C 6 )cycloalkyl, halo(C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkoxy(C 1 -C 6 )alkyl, aryl; wherein said aryl is optionally substituted with one or more substituents independently selected from R 6 , or wherein said aryl is optionally benzodioxole; and wherein said (C 1 -C 6 )alkyl, (C 3 -C 6 )cycloalkyl are optionally substituted with one or more substituents independently selected from R 7 ; R 6 consists of halogen, cyano, hydroxyl, (C 1 -C 4 )alkyl, halo(C 1 -C 4 )alkyl, (C 1 -C 4 )alkyloxy, - S(O) 2 R x , -S(O) 2 NR a R b , -C(O)R x , -C(O)NR a R b and -OR x ; R 7 consists of halogen, hydroxyl, cyano, (C 1 -C 4 )alk0xy, -C(O)NR a R b , -C(O)OR a , -S(O) 2 R x , -S(O) 2 NR a R b , -OR x , and -SR x ; R x consists of (C 1 -C 6 )alkyl and (C 3 -C 6 )cycloalkyl; R a and R b are independently selected from the group consisting of hydrogen, (C 1 -C 4 )alkyl, phenyl-(C 1 -C 4 )alkyl, or R a and R b together with the nitrogen to which they are attached form a 4-6 membered heterocycloalkyl, wherein said heterocycloalkyl is optionally substituted with one or more (C 1 -C 4 )alkyl, -C(O)R x ; or pharmaceutically acceptable salts, hydrates or solvates thereof. <EOS>